Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Butterfield

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Cancer Gene Therapy|October 19, 2002
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccinesAntoni Ribas, Saral N Amarnani, Georgette M Buga, et al.
Hepatology (Baltimore, Md.)|October 15, 2013
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaYuan Hong, Yibing Peng, Z Sheng Guo, et al.
Plos One|July 21, 2015
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma PatientsAhmad A Tarhini, Yan Lin, Haris Zahoor, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Brain, Behavior, and Immunity|April 28, 2020
Adverse childhood experiences (ACEs), cell-mediated immunity, and survival in the context of cancerJennifer L Steel, Michael Antoni, Ritambhara Pathak, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Cancer Gene Therapy|October 19, 2002
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccinesAntoni Ribas, Saral N Amarnani, Georgette M Buga, et al.
Hepatology (Baltimore, Md.)|October 15, 2013
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaYuan Hong, Yibing Peng, Z Sheng Guo, et al.
Plos One|July 21, 2015
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma PatientsAhmad A Tarhini, Yan Lin, Haris Zahoor, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Brain, Behavior, and Immunity|April 28, 2020
Adverse childhood experiences (ACEs), cell-mediated immunity, and survival in the context of cancerJennifer L Steel, Michael Antoni, Ritambhara Pathak, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Pageof 18